The evolving landscape of Plasmodium falciparum necessitates a dynamic approach to therapy guidelines. Current recommendations, often guided by the World Health Organization WHO, prioritize the use of artemisinin-based combination therapies (ACTs) as first-line therapy in most endemic regions. However, the rise of artemisinin resistance demands car

Generic drugs offer a cost-effective alternative to brand-name medications. They contain the comparable active ingredients as their brand-name counterparts and are held to the strict quality standards by regulatory agencies like the FDA. When a patent on a brand-name drug runs out, generic versions can be produced. Choosing a generic drug can assis